216 related articles for article (PubMed ID: 34535181)
1. A recurrent RYR1 mutation associated with early-onset hypotonia and benign disease course.
Biancalana V; Rendu J; Chaussenot A; Mecili H; Bieth E; Fradin M; Mercier S; Michaud M; Nougues MC; Pasquier L; Sacconi S; Romero NB; Marcorelles P; Authier FJ; Gelot Bernabe A; Uro-Coste E; Cances C; Isidor B; Magot A; Minot-Myhie MC; Péréon Y; Perrier-Boeswillwald J; Bretaudeau G; Dondaine N; Bouzenard A; Pizzimenti M; Eymard B; Ferreiro A; Laporte J; Fauré J; Böhm J
Acta Neuropathol Commun; 2021 Sep; 9(1):155. PubMed ID: 34535181
[TBL] [Abstract][Full Text] [Related]
2. Samaritan myopathy, an ultimately benign congenital myopathy, is caused by a RYR1 mutation.
Böhm J; Leshinsky-Silver E; Vassilopoulos S; Le Gras S; Lerman-Sagie T; Ginzberg M; Jost B; Lev D; Laporte J
Acta Neuropathol; 2012 Oct; 124(4):575-81. PubMed ID: 22752422
[TBL] [Abstract][Full Text] [Related]
3. Common and variable clinical, histological, and imaging findings of recessive RYR1-related centronuclear myopathy patients.
Abath Neto O; Moreno CAM; Malfatti E; Donkervoort S; Böhm J; Guimarães JB; Foley AR; Mohassel P; Dastgir J; Bharucha-Goebel DX; Monges S; Lubieniecki F; Collins J; Medne L; Santi M; Yum S; Banwell B; Salort-Campana E; Rendu J; Fauré J; Yis U; Eymard B; Cheraud C; Schneider R; Thompson J; Lornage X; Mesrob L; Lechner D; Boland A; Deleuze JF; Reed UC; Oliveira ASB; Biancalana V; Romero NB; Bönnemann CG; Laporte J; Zanoteli E
Neuromuscul Disord; 2017 Nov; 27(11):975-985. PubMed ID: 28818389
[TBL] [Abstract][Full Text] [Related]
4. A novel late-onset axial myopathy associated with mutations in the skeletal muscle ryanodine receptor (RYR1) gene.
Løseth S; Voermans NC; Torbergsen T; Lillis S; Jonsrud C; Lindal S; Kamsteeg EJ; Lammens M; Broman M; Dekomien G; Maddison P; Muntoni F; Sewry C; Radunovic A; de Visser M; Straub V; van Engelen B; Jungbluth H
J Neurol; 2013 Jun; 260(6):1504-10. PubMed ID: 23329375
[TBL] [Abstract][Full Text] [Related]
5. RYR1-Related Myopathies: Clinical, Histopathologic and Genetic Heterogeneity Among 17 Patients from a Portuguese Tertiary Centre.
Samões R; Oliveira J; Taipa R; Coelho T; Cardoso M; Gonçalves A; Santos R; Melo Pires M; Santos M
J Neuromuscul Dis; 2017; 4(1):67-76. PubMed ID: 28269792
[TBL] [Abstract][Full Text] [Related]
6. Late-onset axial myopathy with cores due to a novel heterozygous dominant mutation in the skeletal muscle ryanodine receptor (RYR1) gene.
Jungbluth H; Lillis S; Zhou H; Abbs S; Sewry C; Swash M; Muntoni F
Neuromuscul Disord; 2009 May; 19(5):344-7. PubMed ID: 19303294
[TBL] [Abstract][Full Text] [Related]
7. Homozygous/compound heterozygote RYR1 gene variants: Expanding the clinical spectrum.
Alkhunaizi E; Shuster S; Shannon P; Siu VM; Darilek S; Mohila CA; Boissel S; Ellezam B; Fallet-Bianco C; Laberge AM; Zandberg J; Injeyan M; Hazrati LN; Hamdan F; Chitayat D
Am J Med Genet A; 2019 Mar; 179(3):386-396. PubMed ID: 30652412
[TBL] [Abstract][Full Text] [Related]
8. RYR1 mutations as a cause of ophthalmoplegia, facial weakness, and malignant hyperthermia.
Shaaban S; Ramos-Platt L; Gilles FH; Chan WM; Andrews C; De Girolami U; Demer J; Engle EC
JAMA Ophthalmol; 2013 Dec; 131(12):1532-40. PubMed ID: 24091937
[TBL] [Abstract][Full Text] [Related]
9. RYR1 causing distal myopathy.
Laughlin RS; Niu Z; Wieben E; Milone M
Mol Genet Genomic Med; 2017 Nov; 5(6):800-804. PubMed ID: 29178655
[TBL] [Abstract][Full Text] [Related]
10. Correlation of phenotype with genotype and protein structure in RYR1-related disorders.
Todd JJ; Sagar V; Lawal TA; Allen C; Razaqyar MS; Shelton MS; Chrismer IC; Zhang X; Cosgrove MM; Kuo A; Vasavada R; Jain MS; Waite M; Rajapakse D; Witherspoon JW; Wistow G; Meilleur KG
J Neurol; 2018 Nov; 265(11):2506-2524. PubMed ID: 30155738
[TBL] [Abstract][Full Text] [Related]
11. First genomic rearrangement of the RYR1 gene associated with an atypical presentation of lethal neonatal hypotonia.
Monnier N; Laquerrière A; Marret S; Goldenberg A; Marty I; Nivoche Y; Lunardi J
Neuromuscul Disord; 2009 Oct; 19(10):680-4. PubMed ID: 19734047
[TBL] [Abstract][Full Text] [Related]
12. Ryanodine receptor 1-related disorders: an historical perspective and proposal for a unified nomenclature.
Lawal TA; Todd JJ; Witherspoon JW; Bönnemann CG; Dowling JJ; Hamilton SL; Meilleur KG; Dirksen RT
Skelet Muscle; 2020 Nov; 10(1):32. PubMed ID: 33190635
[TBL] [Abstract][Full Text] [Related]
13. RYR1-related myopathies: a wide spectrum of phenotypes throughout life.
Snoeck M; van Engelen BG; Küsters B; Lammens M; Meijer R; Molenaar JP; Raaphorst J; Verschuuren-Bemelmans CC; Straathof CS; Sie LT; de Coo IF; van der Pol WL; de Visser M; Scheffer H; Treves S; Jungbluth H; Voermans NC; Kamsteeg EJ
Eur J Neurol; 2015 Jul; 22(7):1094-112. PubMed ID: 25960145
[TBL] [Abstract][Full Text] [Related]
14. An autosomal dominant congenital myopathy with cores and rods is associated with a neomutation in the RYR1 gene encoding the skeletal muscle ryanodine receptor.
Monnier N; Romero NB; Lerale J; Nivoche Y; Qi D; MacLennan DH; Fardeau M; Lunardi J
Hum Mol Genet; 2000 Nov; 9(18):2599-608. PubMed ID: 11063719
[TBL] [Abstract][Full Text] [Related]
15. 'Dusty core disease' (DuCD): expanding morphological spectrum of RYR1 recessive myopathies.
Garibaldi M; Rendu J; Brocard J; Lacene E; Fauré J; Brochier G; Beuvin M; Labasse C; Madelaine A; Malfatti E; Bevilacqua JA; Lubieniecki F; Monges S; Taratuto AL; Laporte J; Marty I; Antonini G; Romero NB
Acta Neuropathol Commun; 2019 Jan; 7(1):3. PubMed ID: 30611313
[TBL] [Abstract][Full Text] [Related]
16. Severe congenital RYR1-associated myopathy: the expanding clinicopathologic and genetic spectrum.
Bharucha-Goebel DX; Santi M; Medne L; Zukosky K; Dastgir J; Shieh PB; Winder T; Tennekoon G; Finkel RS; Dowling JJ; Monnier N; Bönnemann CG
Neurology; 2013 Apr; 80(17):1584-9. PubMed ID: 23553484
[TBL] [Abstract][Full Text] [Related]
17. Muscle weakness in Ryr1I4895T/WT knock-in mice as a result of reduced ryanodine receptor Ca2+ ion permeation and release from the sarcoplasmic reticulum.
Loy RE; Orynbayev M; Xu L; Andronache Z; Apostol S; Zvaritch E; MacLennan DH; Meissner G; Melzer W; Dirksen RT
J Gen Physiol; 2011 Jan; 137(1):43-57. PubMed ID: 21149547
[TBL] [Abstract][Full Text] [Related]
18. Novel excitation-contraction uncoupled RYR1 mutations in patients with central core disease.
Kraeva N; Zvaritch E; Rossi AE; Goonasekera SA; Zaid H; Frodis W; Kraev A; Dirksen RT; Maclennan DH; Riazi S
Neuromuscul Disord; 2013 Feb; 23(2):120-32. PubMed ID: 23183335
[TBL] [Abstract][Full Text] [Related]
19. Malignant hyperthermia in Japan: mutation screening of the entire ryanodine receptor type 1 gene coding region by direct sequencing.
Ibarra M CA; Wu S; Murayama K; Minami N; Ichihara Y; Kikuchi H; Noguchi S; Hayashi YK; Ochiai R; Nishino I
Anesthesiology; 2006 Jun; 104(6):1146-54. PubMed ID: 16732084
[TBL] [Abstract][Full Text] [Related]
20. Congenital muscle disorders with cores: the ryanodine receptor calcium channel paradigm.
Treves S; Jungbluth H; Muntoni F; Zorzato F
Curr Opin Pharmacol; 2008 Jun; 8(3):319-26. PubMed ID: 18313359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
